Gartner, Inc. Deferred Revenue Recognized
Gartner, Inc. (IT) reported Deferred Revenue Recognized of $1.30 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-04
- Gartner, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $1.30B, a 8.33% increase year-over-year.
- Gartner, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $1.10B, a 10.00% increase year-over-year.
- Gartner, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $1.10B, a 0.00% change year-over-year.
- Gartner, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $1.20B, a 0.00% change year-over-year.
- Gartner, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $2.40B, a 4.35% increase from fiscal 2024.
- Gartner, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $2.30B, a 15.00% increase from fiscal 2023.
- Gartner, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $2.00B, a 5.26% increase from fiscal 2022.
- Gartner, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $1.90B, a 18.75% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.30B 10-Q · filed 2026-08-04 | $1.90B 10-Q · filed 2026-08-04 | ||||||
| 2026-03-31 | $1.10B 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | $2.40B 10-K · filed 2026-02-12 | |||||||
| 2025-09-30 | $1.10B 10-Q · filed 2025-11-04 | $2.20B 10-Q · filed 2025-11-04 | ||||||
| 2025-06-30 | $1.20B 10-Q · filed 2026-08-04 | $1.80B 10-Q · filed 2026-08-04 | ||||||
| 2025-03-31 | $1.00B 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | $2.30B 10-K · filed 2026-02-12 | |||||||
| 2024-09-30 | $1.10B 10-Q · filed 2025-11-04 | $2.10B 10-Q · filed 2025-11-04 | ||||||
| 2024-06-30 | $1.20B 10-Q · filed 2025-08-05 | $1.70B 10-Q · filed 2025-08-05 | ||||||
| 2024-03-31 | $1.00B 10-Q · filed 2025-05-06 | |||||||
| 2023-12-31 | $2.00B 10-K · filed 2026-02-12 | |||||||
| 2023-09-30 | $1.00B 10-Q · filed 2024-11-05 | $1.90B 10-Q · filed 2024-11-05 | ||||||
| 2023-06-30 | $1.20B 10-Q · filed 2024-07-30 | $1.60B 10-Q · filed 2024-07-30 | ||||||
| 2023-03-31 | $900.00M 10-Q · filed 2024-04-30 | $924.90M 10-Q · filed 2023-05-02 | ||||||
| 2022-12-31 | $1.90B 10-K · filed 2025-02-13 | |||||||
| 2022-09-30 | $900.00M 10-Q · filed 2023-11-03 | $931.60M 10-Q · filed 2022-11-01 | $1.80B 10-Q · filed 2023-11-03 | |||||
| 2022-06-30 | $1.00B 10-Q · filed 2023-08-01 | $956.40M 10-Q · filed 2022-08-02 | $1.40B 10-Q · filed 2023-08-01 | |||||
| 2022-03-31 | $833.90M 10-Q · filed 2023-05-02 | |||||||
| 2021-12-31 | $1.60B 10-K · filed 2024-02-15 | $1.61B 10-K · filed 2022-02-23 | ||||||
| 2021-09-30 | $818.40M 10-Q · filed 2022-11-01 | $1.50B 10-Q · filed 2022-11-01 | $1.51B 10-Q · filed 2021-11-02 | |||||
| 2021-06-30 | $817.30M 10-Q · filed 2022-08-02 | $1.30B 10-Q · filed 2022-08-02 | $1.26B 10-Q · filed 2021-08-03 | |||||
| 2021-03-31 | $726.70M 10-Q · filed 2022-05-03 | |||||||
| 2020-12-31 | $1.50B 10-K · filed 2023-02-16 | $1.49B 10-K · filed 2021-02-24 | ||||||
| 2020-09-30 | $681.60M 10-Q · filed 2021-11-02 | $1.35B 10-Q · filed 2021-11-02 | ||||||
| 2020-06-30 | $692.60M 10-Q · filed 2021-08-03 | $1.09B 10-Q · filed 2021-08-03 | ||||||
| 2020-03-31 | $658.40M 10-Q · filed 2021-05-04 | |||||||
| 2019-12-31 | $1.44B 10-K · filed 2022-02-23 | |||||||
| 2019-09-30 | $675.20M 10-Q · filed 2020-11-03 | $1.31B 10-Q · filed 2020-11-03 | ||||||
| 2019-06-30 | $708.30M 10-Q · filed 2020-08-04 | $1.06B 10-Q · filed 2020-08-04 | ||||||
| 2019-03-31 | $650.10M 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $1.29B 10-K · filed 2021-02-24 | |||||||
| 2018-09-30 | $642.00M 10-Q · filed 2019-10-31 | $1.16B 10-Q · filed 2019-10-31 | ||||||
| 2018-06-30 | $651.90M 10-Q · filed 2019-07-30 | $969.30M 10-Q · filed 2019-07-30 | ||||||
| 2018-03-31 | $605.50M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |